latest news releases from the newsroom
Aventine Renewable Energy Holdings, Inc.
Aventine Reports 4th Quarter and Full Year Results
PEKIN, Ill., March 16, 2009 (GLOBE NEWSWIRE) -- Aventine Renewable Energy Holdings, Inc. (NYSE:AVR), a producer and marketer of clean renewable energy, today released results for its fourth quarter and full-year ended December 31, 2008. The net loss for the quarter was $36.9 million, or $0.86 per diluted share, as compared to net income of $3.3 million, or $0.08 per diluted share, in the fourth quarter of 2007.
Hagens Berman, LLP
Oppenheimer Champion Income Fund Holders Turn to Hagens Berman Sobol Shapiro for Class-Action Representation -- OPCHX, OCHBX, OCHCX, OCHNX, OCHYX
SEATTLE, March 16, 2009 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro (HBSS), a nationally recognized class-action firm that filed a lawsuit against Oppenheimer Funds (Nasdaq:OPCHX) (Nasdaq:OCHBX) (Nasdaq:OCHCX) (Nasdaq:OCHNX) (Nasdaq:OCHYX), reports investors from across the country have contacted the firm, all detailing similar stories of significant financial losses they claim resulted from Oppenheimer's alleged fraudulent marketing of the fund.
HickoryTech Corporation Announces the Appointment of Diane Dewbrey to the Board of Directors
MANKATO, Minn., March 16, 2009 (GLOBE NEWSWIRE) -- HickoryTech Corporation (Nasdaq:HTCO) announced the selection of Diane L. Dewbrey as a director on HickoryTech's 10-member board. Dewbrey will fill the independent board position vacated on Dec. 31, 2008 by James H. Holdredge and will complete the remainder of Holdredge's term, which expires in 2010. Holdredge retired in December after serving on the Board since 1992. Dewbrey will serve on the compensation committee of the board.
Advanced Battery Technologies, Inc.
Advanced Battery Technologies Reports Full Year 2008 Financial Results
NEW YORK and HARBIN, China, March 16, 2009 (GLOBE NEWSWIRE) -- Advanced Battery Technologies, Inc. (Nasdaq:ABAT), a leading developer, manufacturer and distributor of rechargeable Polymer Lithium-Ion (PLI) batteries, today announced its financial results for the year ended December 31, 2008.
Bell Microproducts Inc.
Bell Microproducts Separates Roles of Chairman and Chief Executive in Accordance With Corporate Governance Best Practices
SAN JOSE, Calif., March 16, 2009 (GLOBE NEWSWIRE) -- Bell Microproducts Inc. (Pink Sheets:BELM), one of the world's largest value-added distributors of storage and computing technology, announced today the separation of Chairman and Chief Executive functions in accordance with corporate governance best practices. Independent director and Audit Committee Chair James E. Ousley has been appointed Chairman of the Board of Directors; W. Donald Bell will continue as President and Chief Executive Officer of the company. Board member Peter Hanelt, a designated 'financial expert' as defined by the Securities and Exchange Commission (SEC), has been appointed by the Board to succeed Mr. Ousley as Audit Committee Chair.
Triangle Capital Corporation
Triangle Capital Corporation Invests $5.2 Million in Tulsa Inspection Resources, Inc.
RALEIGH, N.C., March 16, 2009 (GLOBE NEWSWIRE) -- Triangle Capital Corporation (Nasdaq:TCAP) ("Triangle" or the "Company"), a leading specialty finance company that provides customized financing solutions to lower middle market companies located throughout the United States, today announced that it closed a $5.2 million investment in Tulsa Inspection Resources, Inc. ("TIR") consisting of $5.0 million in subordinated debt with warrants and $0.2 million in equity. TIR is a leading independent provider of pipeline inspection services for the oil and gas industry.
Rockwell Medical, Inc.
Rockwell Medical Technologies, Inc. Reports Fourth Quarter 2008 Results; Sales Increase 20% Year-Over-Year to $51.6 Million
WIXOM, Mich., March 16, 2009 (GLOBE NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ERSD), chronic kidney disease (CKD), and iron deficiency anemia, reported record fourth quarter 2008 sales of $13.5 million, up 13.3% from $11.9 million for the same period of 2007. Loss for the fourth quarter was $3.0 million or ($.22) per share compared to $1.2 million or ($.09) per share for the same period of 2007.